Are peptides legal in California?
Peptide drugs are federally regulated. State pharmacy law governs compounding and dispensing, and the state board follows FDA 503A/503B bulk-substance rules. California's Board of Pharmacy enforces additional sterile-compounding licensure beyond federal rules, and Proposition 65 labeling can apply to some products. Enforcement actions against peptide clinics have increased.
Compounding
Sterile compounding requires separate CA licensure
Primary citations
- Cal. Bus. & Prof. Code § 4127
- 16 CCR § 1735
What this means practically
Approved peptide drugs such as semaglutide, tirzepatide, and tesamorelin are obtainable in California with a valid prescription from a licensed practitioner, dispensed by a licensed pharmacy. Telehealth access is permitted.
Peptides on the FDA's 503A Category 2 bulk list — including BPC-157, CJC-1295, ipamorelin, and thymosin alpha-1 — cannot lawfully be compounded by any pharmacy in California, regardless of state rules, because the restriction is federal. Products sold online as "research chemicals" are not approved for human use.
This page tracks status only. It is not legal advice, and state boards update guidance frequently.